PPARA and metabolic dysfunction-associated steatotic liver disease: In agreement, hepatocyte-specific ablation of Ppara is associated with liver inflammation and MASLD in HFD-fed mice,35 while mice overexpressing Pgc1a exhibit reduced inflammation and are protected from hepatic steatosis.37